603222 Stock Overview
Researches, develops, produces, and sells human medicines and medical devices in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Chimin Health Management Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.77 |
| 52 Week High | CN¥9.33 |
| 52 Week Low | CN¥4.70 |
| Beta | 0.031 |
| 11 Month Change | 19.35% |
| 3 Month Change | 39.25% |
| 1 Year Change | -14.62% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -28.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603222 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.1% | -1.8% | -2.6% |
| 1Y | -14.6% | -7.0% | 4.2% |
Return vs Industry: 603222 underperformed the CN Pharmaceuticals industry which returned -7% over the past year.
Return vs Market: 603222 underperformed the CN Market which returned 4.2% over the past year.
Price Volatility
| 603222 volatility | |
|---|---|
| 603222 Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603222 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603222's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,947 | Yunfei Tian | www.chimin.cn |
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products.
Chimin Health Management Co., Ltd. Fundamentals Summary
| 603222 fundamental statistics | |
|---|---|
| Market cap | CN¥4.08b |
| Earnings (TTM) | -CN¥82.14m |
| Revenue (TTM) | CN¥899.55m |
4.5x
P/S Ratio-49.7x
P/E RatioIs 603222 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603222 income statement (TTM) | |
|---|---|
| Revenue | CN¥899.55m |
| Cost of Revenue | CN¥523.90m |
| Gross Profit | CN¥375.65m |
| Other Expenses | CN¥457.79m |
| Earnings | -CN¥82.14m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 41.76% |
| Net Profit Margin | -9.13% |
| Debt/Equity Ratio | 26.6% |
How did 603222 perform over the long term?
See historical performance and comparison